Cargando…
Modern Management Options for Ph+ ALL
SIMPLE SUMMARY: The use of tyrosine kinase inhibitors has represented a major step forward in the therapy of Philadelphia chromosome positive acute lymphoblastic leukemia. Recent improvements in the therapy are focused on early use of third generation tyrosine kinase inhibitors, their combination wi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558985/ https://www.ncbi.nlm.nih.gov/pubmed/36230478 http://dx.doi.org/10.3390/cancers14194554 |